Last reviewed · How we verify
NCT04925791
Does Limb Pre-Conditioning Reduce Pain After Hip Arthroscopy
NA trial testing standardized pre-conditioning treatment in Hip Injuries in 68 participants. Completed in 20 October 2023.
20 October 2023
Quick facts
| Lead sponsor | Cedars-Sinai Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 68 |
| Start date | 18 October 2021 |
| Primary completion | 20 October 2023 |
| Estimated completion | 20 October 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- standardized pre-conditioning treatment
- Partial occlusion
Conditions studied
- Hip Injuries — all drugs for Hip Injuries →
- Hip Dislocation — all drugs for Hip Dislocation →
- Hip Fractures — all drugs for Hip Fractures →
Sponsor
Cedars-Sinai Medical Center
Who can join
Adults 18 to 55, any sex, with Hip Injuries or Hip Dislocation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine if the utilization of Ischemic Pre-Conditioning 24-hours prior to hip arthroscopy decreases patient's post-operative pain and opioid consumption.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Does Ischemic Preconditioning of the Operative Limb Reduce Pain After Hip Arthroscopy? A Prospective, Single-Blind, Randomized Controlled Trial.
Orner C, Usoro A, Bergeron B, Banffy M. · · 2025 · PMID 40502719 · DOI 10.1177/23259671251343762
Verify or expand the search:
- PubMed search for NCT04925791
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Injuries
Currently open trials in the same condition.
- NCT06288867 — A 12 Months Prospective Study Comparing Functional Outcome Scores in Hip Arthroscopic Labral Repair Versus Debridement · NA · recruiting
- NCT06320925 — SportsPro: Post-Market Clinical Follow Up Study · recruiting
- NCT05762588 — JuggerKnot With Broadband PMCF Study · active not recruiting
- NCT05165927 — Comparison of Methods in Post Operative Hip Arthroscopy Rehabilitation · NA · recruiting
- NCT04028687 — MDR - PMCF Study for Taperloc Complete Stems · recruiting
Other Cedars-Sinai Medical Center trials
Trials by the same sponsor.
- NCT06012487 — Correlates and Control of Blood Pressure Variability · Phase 1 · not yet recruiting
- NCT07495995 — SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis · Phase 2 · not yet recruiting
- NCT07413965 — TAVR vs SAVR in Severe Bicuspid Aortic Stenosis · NA · not yet recruiting
- NCT06521021 — CHOICE to AVOID or RESIST · NA · not yet recruiting
- NCT07499089 — Together-Breast Cancer Support Platform · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04925791 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cedars-Sinai Medical Center
- Last refreshed: 20 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04925791.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing